Dr. John A. Kalapurakal, MD

Dr. Kalapurakal practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Kalapurakal's NPI, 1780659748, was assigned on February 22, 2006. Dr. Kalapurakal graduated from Kottayam Medical College in 1988.

Dr. Kalapurakal's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Kalapurakal's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. Dr. Kalapurakal is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Kalapurakal to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalapurakal practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kalapurakal's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kalapurakal is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kalapurakal's licenses on file in 2 states: Illinois and Pennsylvania.

Dmand AI lists bone cancer radiation, brain cancer radiation and prostate cancer radiation among the conditions Dr. Kalapurakal treats.

CMS data shows 2,811 Medicare services from Dr. Kalapurakal across 19 procedure codes in 2024, for 458 Medicare patients. Medicare paid $194,623 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 458 Medicare patients who saw Dr. Kalapurakal in 2024. The largest group is 75 to 84, with 210 patients. 75% of them have cancer, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalapurakal's median patient age at 76, with 7% women.

In 2024, Dr. Kalapurakal wrote 840 Medicare Part D claims for 184 patients. 81% of them were for generic drugs. CMS names the drug for 746 of them, across 8 drugs with 11 or more claims each, at $383,422 in total drug cost. In 2023, CMS named 656 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kalapurakal for performance year 2024, reported through an alternative payment model (APM). Dr. Kalapurakal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalapurakal as offering telehealth.

Dmand AI links 131 papers to Dr. Kalapurakal, published from 2004 to 2024. 2018 was the busiest year, with 10. The most frequent topics are Kidney Neoplasms, Wilms Tumor and Antineoplastic Combined Chemotherapy Protocols. Dr. Kalapurakal has published most often in Int J Radiat Oncol Biol Phys. Dr. Kalapurakal's most frequent co-authors are Jeffrey S. Dome, MD, James Ian Geller, MD and Elizabeth A. Mullen, FAAP, MD.

Dmand AI links Dr. Kalapurakal to 2 clinical trials. Conditions studied include Glioblastoma, Prostatic Neoplasms and Astrocytoma.

CMS Open Payments shows 2 general payments to Dr. Kalapurakal from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $29.

Dmand AI lists 1 award for Dr. Kalapurakal.

Dr. Kalapurakal graduated from Kottayam Medical College in 1988. Dr. Kalapurakal is a member of ASCO.

Dr. Kalapurakal is in network with 16 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.